Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
CH.1.1.29EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
CH.1.1.29EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CH.1.1.29ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CH.1.1.29ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.55EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.55EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.55ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.55ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.55EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.55EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.55ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.55ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.519EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.519EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.519ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.519ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.519EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.519EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.519ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.519ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.514EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.514EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.514ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.514ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.514EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.514EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.514ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.514ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GT.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
GT.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GT.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
GT.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GT.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GT.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GT.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GT.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.87EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.87EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.87ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.5.87ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.5.87EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.87EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.87ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.87ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XAPEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
XAPEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAPECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
XAPECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XAPEHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XAPEHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used